|
|
|
Parkinson's Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Parkinson's Disease
Please click "Search" to find Parkinson's Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
Your Search Returned No Results. |
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- 50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease - NCT00977184-20892
Conditions: Parkinson Disease
Location: Bethesda, MD
- A Positron Emission Tomography (PET) Brain Imaging Study of Glutamate Receptor 5 in Parkinson and Huntington Diseases - NCT00870974-06510
Conditions: Parkinson Disease - Huntington Disease
Location: New Haven, CT
- A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients - NCT01007630-94085
Conditions: Parkinson's Disease
Location: Sunnyvale, CA
- A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease - NCT00387075-06510
Conditions: Parkinson Disease
Location: New Haven, CT
- A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease - NCT00117195-06510
Conditions: Parkinson's Disease - Parkinsonian Syndrome
Location: New Haven, CT
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-
Conditions: Parkinson's Disease Psychosis
Location: New Bern, NC
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-01655
Conditions: Parkinson's Disease Psychosis
Location: Worcester, MA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-02215
Conditions: Parkinson's Disease Psychosis
Location: Boston, MA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-05401
Conditions: Parkinson's Disease Psychosis
Location: Burlington, VT
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-06030
Conditions: Parkinson's Disease Psychosis
Location: Farmington, CT
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-11725
Conditions: Parkinson's Disease Psychosis
Location: Commack, NY
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-12208
Conditions: Parkinson's Disease Psychosis
Location: Albany, NY
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-19131
Conditions: Parkinson's Disease Psychosis
Location: Philadelphia, PA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-19141
Conditions: Parkinson's Disease Psychosis
Location: Philadelphia, PA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-27705
Conditions: Parkinson's Disease Psychosis
Location: Durham, NC
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-28204
Conditions: Parkinson's Disease Psychosis
Location: Charlotte, NC
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-32405
Conditions: Parkinson's Disease Psychosis
Location: Panama City, FL
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-33064
Conditions: Parkinson's Disease Psychosis
Location: Deerfield Beach, FL
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-34233
Conditions: Parkinson's Disease Psychosis
Location: Sarasota, FL
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-43614
Conditions: Parkinson's Disease Psychosis
Location: Toledo, OH
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-48035
Conditions: Parkinson's Disease Psychosis
Location: Clinton Twp, MI
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-48201
Conditions: Parkinson's Disease Psychosis
Location: Detroit, MI
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-48824
Conditions: Parkinson's Disease Psychosis
Location: East lansing, MI
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-65201
Conditions: Parkinson's Disease Psychosis
Location: Columbia, MO
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-68131
Conditions: Parkinson's Disease Psychosis
Location: Omaha, NE
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-77030
Conditions: Parkinson's Disease Psychosis
Location: Houston, TX
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-80113
Conditions: Parkinson's Disease Psychosis
Location: Englewood, CO
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-90631
Conditions: Parkinson's Disease Psychosis
Location: La Habra, CA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-92653
Conditions: Parkinson's Disease Psychosis
Location: Laguna HIlls, CA
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00658567-93003
Conditions: Parkinson's Disease Psychosis
Location: Ventura, CA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-02215
Conditions: Parkinson's Disease Psychosis
Location: Boston, MA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-02886
Conditions: Parkinson's Disease Psychosis
Location: Warwick, RI
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-04074
Conditions: Parkinson's Disease Psychosis
Location: Scarborough, ME
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-06030
Conditions: Parkinson's Disease Psychosis
Location: Farmington, CT
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-06810
Conditions: Parkinson's Disease Psychosis
Location: Danbury, CT
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-06824
Conditions: Parkinson's Disease Psychosis
Location: Fairfield, CT
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-08755
Conditions: Parkinson's Disease Psychosis
Location: Toms River, NJ
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-11725
Conditions: Parkinson's Disease Psychosis
Location: Commack, NY
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-14618
Conditions: Parkinson's Disease Psychosis
Location: Rochester, NY
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-28144
Conditions: Parkinson's Disease Psychosis
Location: Salisbury, NC
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-28204
Conditions: Parkinson's Disease Psychosis
Location: Charlotte, NC
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-28562
Conditions: Parkinson's Disease Psychosis
Location: New Bern, NC
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-28806
Conditions: Parkinson's Disease Psychosis
Location: Asheville, NC
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-30033
Conditions: Parkinson's Disease Psychosis
Location: Decatur, GA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-30912
Conditions: Parkinson's Disease Psychosis
Location: Augusta, GA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-32209
Conditions: Parkinson's Disease Psychosis
Location: Jacksonville, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-33060
Conditions: Parkinson's Disease Psychosis
Location: Pompano Beach, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-33064
Conditions: Parkinson's Disease Psychosis
Location: Deerfield Beach, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-33486
Conditions: Parkinson's Disease Psychosis
Location: Boca Raton, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-33701
Conditions: Parkinson's Disease Psychosis
Location: St. Petersberg, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-33952
Conditions: Parkinson's Disease Psychosis
Location: Port Charlotte, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-34233
Conditions: Parkinson's Disease Psychosis
Location: Sarasota, FL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-37027
Conditions: Parkinson's Disease Psychosis
Location: Brentwood, TN
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-48037
Conditions: Parkinson's Disease Psychosis
Location: Clinton Twp, MI
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-48201
Conditions: Parkinson's Disease Psychosis
Location: Detroit, MI
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-48824
Conditions: Parkinson's Disease Psychosis
Location: East Lansing, MI
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-62794
Conditions: Parkinson's Disease Psychosis
Location: Springfield, IL
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-65201
Conditions: Parkinson's Disease Psychosis
Location: Columbia, MO
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-80113
Conditions: Parkinson's Disease Psychosis
Location: Englewood, CO
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-85013
Conditions: Parkinson's Disease Psychosis
Location: Phoenix, AZ
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-85234
Conditions: Parkinson's Disease Psychosis
Location: Gilbert, AZ
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-91335
Conditions: Parkinson's Disease Psychosis
Location: Reseda, CA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-92697
Conditions: Parkinson's Disease Psychosis
Location: Irvine, CA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-92708
Conditions: Parkinson's Disease Psychosis
Location: Fountain Valley, CA
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis - NCT00550238-93003
Conditions: Parkinson's Disease Psychosis
Location: Ventura, CA
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-06510
Conditions: Parkinson's Disease
Location: New Haven, CT
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-08901
Conditions: Parkinson's Disease
Location: New Brunswick, NJ
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-10032
Conditions: Parkinson's Disease
Location: New York, NY
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-11725
Conditions: Parkinson's Disease
Location: Commack, NY
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-12208
Conditions: Parkinson's Disease
Location: Albany, NY
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-27607
Conditions: Parkinson's Disease
Location: Raleigh, NC
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-27707
Conditions: Parkinson's Disease
Location: Durham, NC
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-29401
Conditions: Parkinson's Disease
Location: Charleston, SC
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-33713
Conditions: Parkinson's Disease
Location: Saint Petersburg, FL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-33980A
Conditions: Parkinson's Disease
Location: Port Charlotte, FL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-33980B
Conditions: Parkinson's Disease
Location: Port Charlotte, FL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-34471
Conditions: Parkinson's Disease
Location: Ocala, FL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-35233
Conditions: Parkinson's Disease
Location: Birmingham, AL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-43614
Conditions: Parkinson's Disease
Location: Toledo, OH
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-45219
Conditions: Parkinson's Disease
Location: Cincinatti, OH
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-48025
Conditions: Parkinson's Disease
Location: Bingham Farms, MI
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-50309
Conditions: Parkinson's Disease
Location: Des Moines, IA
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-53233
Conditions: Parkinson's Disease
Location: Milwaukee, WI
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-60611
Conditions: Parkinson's Disease
Location: Chicago, IL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-60612
Conditions: Parkinson's Disease
Location: Chicago, IL
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-66160
Conditions: Parkinson's Disease
Location: Kansas City, KS
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-72205
Conditions: Parkinson's Disease
Location: Little Rock, AR
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-75390
Conditions: Parkinson's Disease
Location: Dallas, TX
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-77030
Conditions: Parkinson's Disease
Location: Houston, TX
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-83702
Conditions: Parkinson's Disease
Location: Boise, ID
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-90502
Conditions: Parkinson's Disease
Location: Torrance, CA
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-92037
Conditions: Parkinson's Disease
Location: La Jolla, CA
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). - NCT00974974-94085
Conditions: Parkinson's Disease
Location: Sunnyvale, CA
- Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients (Study P05550AM2) - NCT00845000-97239
Conditions: Movement Disorders - Dyskinesias - Neurodegenerative Diseases - Central Nervous System Diseases - Brain Diseases
Location: Portland, OR
- Affect of Different Types of Anesthetic Techniques on Cognition in Patients With Parkinson's Disease - NCT00615472-10032
Conditions: Parkinson's Disease
Location: New York, NY
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-33606
Conditions: Parkinson's Disease
Location: Tampa, FL
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-77030
Conditions: Parkinson's Disease
Location: Houston, TX
- An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease - NCT00853879-11030
Conditions: Parkinson's Disease
Location: Manhasset, NY
- Biomarkers of Risk of Parkinson Disease - NCT00775853-20892
Conditions: Parkinson Disease - Autonomic Nervous System Diseases - Pure Autonomic Failure
Location: Bethesda, MD
- Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders - NCT00001178-20892
Conditions: Alzheimer's Disease - Dementia - Down's Syndrome
Location: Bethesda, MD
- Characteristics of Parkinson's Disease Associated With the LRRK-2 Gene Mutation - NCT00467090-20892
Conditions: Parkinson Disease
Location: Bethesda, MD
- Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease - NCT00571285-30322
Conditions: Parkinson's Disease
Location: Atlanta, GA
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-01655
Conditions: Multiple System Atrophy
Location: Worcester, MA
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-14618
Conditions: Multiple System Atrophy
Location: Rochester, NY
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-19107
Conditions: Multiple System Atrophy
Location: Philadelphia, PA
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-20007
Conditions: Multiple System Atrophy
Location: Washington, DC
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-37232
Conditions: Multiple System Atrophy
Location: Nashville, TN
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-44106
Conditions: Multiple System Atrophy
Location: Cleveland, OH
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-48105
Conditions: Multiple System Atrophy
Location: Ann Arbor, MI
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-55905
Conditions: Multiple System Atrophy
Location: Rochester, MN
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-63110
Conditions: Multiple System Atrophy
Location: St. Louis, MO
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-77030
Conditions: Multiple System Atrophy
Location: Houston, TX
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-92093
Conditions: Multiple System Atrophy
Location: La Jolla, CA
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-92697
Conditions: Multiple System Atrophy
Location: Irvine, CA
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) - NCT00977665-94085
Conditions: Multiple System Atrophy
Location: Sunnyvale, CA
- Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease - NCT00492115-92093
Conditions: Parkinson's Disease - Sleep Disordered Breathing
Location: San Diego, CA
- Cognitive Rehabilitation in PD - NCT01085968-94553
Conditions: Parkinson's Disease
Location: Martinez, CA
- Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease - NCT00758368-97239
Conditions: Parkinson's Disease
Location: Portland, OR
- Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia - NCT00917280-63110
Conditions: Parkinson's Disease
Location: St. Louis, MO
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-02886
Conditions: Parkinson's Disease
Location: Warwick, RI
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-06510
Conditions: Parkinson's Disease
Location: New Haven, CT
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-10003
Conditions: Parkinson's Disease
Location: New York, NY
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-10032
Conditions: Parkinson's Disease
Location: New York, NY
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-19104
Conditions: Parkinson's Disease
Location: Philadelphia, PA
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-21287
Conditions: Parkinson's Disease
Location: Baltimore, MD
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-38136
Conditions: Parkinson's Disease
Location: Memphis, TN
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-54449
Conditions: Parkinson's Disease
Location: Marshfield, WI
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-55427
Conditions: Parkinson's Disease
Location: Golden Valley, MN
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-60026
Conditions: Parkinson's Disease
Location: Glenview, IL
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-60612
Conditions: Parkinson's Disease
Location: Chicago, IL
- Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-94089
Conditions: Parkinson's Disease
Location: Sunnyvale, CA
- Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson's Disease - NCT00921128-20892
Conditions: Parkinson's Disease
Location: Bethesda, MD
- Coping With Depression in Parkinson's Disease - NCT00464464-08854
Conditions: Parkinson's Disease - Depression
Location: Piscataway, NJ
- Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease - NCT00993291-37232
Conditions: Gait - Parkinson's Disease
Location: Nashville, TN
- Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease - NCT00552474-
Conditions: Parkinson Disease - Movement Disorders
Location: Madison, WI
- Development of Cognitive Assessment Tools in Parkinson Disease - NCT00556764-06510
Conditions: Parkinson Disease
Location: New Haven, CT
- Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease - NCT00315250-06510
Conditions: Parkinson's Disease - Parkinsonian Syndrome
Location: New Haven, CT
- Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation - NCT00608231-37232
Conditions: Parkinson's Disease - Essential Tremor - Dystonia
Location: Nashville, TN
- Early Parkinson's Disease (PD) Cross-Sectional - NCT00817453-77030
Conditions: Parkinson's Disease
Location: Houston, TX
- Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease - NCT00819949-02908
Conditions: Parkinson's Disease
Location: Providence, RI
- Effects of Aerobic Exercise in Parkinson's Disease - NCT00784563-52246
Conditions: Parkinson Disease
Location: Iowa City, IA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-
Conditions: Parkinson Disease
Location: Los Angeles, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-02118
Conditions: Parkinson Disease
Location: Boston, MA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-02215
Conditions: Parkinson Disease
Location: Boston, MA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-02886
Conditions: Parkinson Disease
Location: Warwick, RI
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-05405
Conditions: Parkinson Disease
Location: Burlington, VT
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-06510
Conditions: Parkinson Disease
Location: New Haven, CT
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10003A
Conditions: Parkinson Disease
Location: New York, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10003B
Conditions: Parkinson Disease
Location: New York, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10021A
Conditions: Parkinson Disease
Location: New York, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10021B
Conditions: Parkinson Disease
Location: New York, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10032
Conditions: Parkinson Disease
Location: New York, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-10461
Conditions: Parkinson Disease
Location: Bronx, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-11030
Conditions: Parkinson Disease
Location: Manhasset, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-11203
Conditions: Parkinson Disease
Location: Brooklyn, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-12208
Conditions: Parkinson Disease
Location: Albany, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-14618
Conditions: Parkinson Disease
Location: Rochester, NY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-17033
Conditions: Parkinson Disease
Location: Hershey, PA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-19107
Conditions: Parkinson Disease
Location: Philadelphia, PA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-21075
Conditions: Parkinson Disease
Location: Elkridge, MD
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-21201
Conditions: Parkinson Disease
Location: Baltimore, MD
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-21287
Conditions: Parkinson Disease
Location: Baltimore, MD
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-27705
Conditions: Parkinson Disease
Location: Durham, NC
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-29401
Conditions: Parkinson Disease
Location: Charleston, SC
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-30329
Conditions: Parkinson Disease
Location: Atlanta, GA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-30912
Conditions: Parkinson Disease
Location: Augusta, GA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-32610
Conditions: Parkinson Disease
Location: Gainsville, FL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-33136
Conditions: Parkinson Disease
Location: Miami, FL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-33606
Conditions: Parkinson Disease
Location: Tampa, FL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-35233
Conditions: Parkinson Disease
Location: Birmingham, AL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-38104
Conditions: Parkinson Disease
Location: Memphis, TN
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-40202
Conditions: Parkinson Disease
Location: Louisville, KY
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-43210
Conditions: Parkinson Disease
Location: Columbus, OH
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-43614
Conditions: Parkinson Disease
Location: Toledo, OH
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-44195
Conditions: Parkinson Disease
Location: Cleveland, OH
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-45219
Conditions: Parkinson Disease
Location: Cincinnati, OH
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-46202
Conditions: Parkinson Disease
Location: Indianapolis, IN
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-52242
Conditions: Parkinson Disease
Location: Iowa City, IA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-53226
Conditions: Parkinson Disease
Location: Milwaukee, WI
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-55455
Conditions: Parkinson Disease
Location: Minneapolis, MN
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-60611
Conditions: Parkinson Disease
Location: Chicago, IL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-60612
Conditions: Parkinson Disease
Location: Chicago, IL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-60637
Conditions: Parkinson Disease
Location: Chicago, IL
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-63110
Conditions: Parkinson Disease
Location: St Louis, MO
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-66160
Conditions: Parkinson Disease
Location: Kansas City, KS
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-70121
Conditions: Parkinson Disease
Location: New Orleans, LA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-71103
Conditions: Parkinson Disease
Location: Shreveport, LA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-77030
Conditions: Parkinson Disease
Location: Houston, TX
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-80045
Conditions: Parkinson Disease
Location: Aurora, CO
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-80113
Conditions: Parkinson Disease
Location: Littleton, CO
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-85013
Conditions: Parkinson Disease
Location: Phoenix, AZ
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-85260
Conditions: Parkinson Disease
Location: Scottsdale, AZ
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-85351
Conditions: Parkinson Disease
Location: Sun City, AZ
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-92093
Conditions: Parkinson Disease
Location: La Jolla, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-92697
Conditions: Parkinson Disease
Location: Irvine, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-92708
Conditions: Parkinson Disease
Location: Fountain Valley, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-94085
Conditions: Parkinson Disease
Location: Sunnyvale, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-95817
Conditions: Parkinson Disease
Location: Sacramento, CA
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-97239
Conditions: Parkinson Disease
Location: Portland, OR
- Effects of Coenzyme Q10 (CoQ) in Parkinson Disease - NCT00740714-98034
Conditions: Parkinson Disease
Location: Kirkland, WA
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) - NCT00382824-01805
Conditions: Progressive Supranuclear Palsy - Atypical Parkinsonism
Location: Burlington, MA
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) - NCT00382824-02215
Conditions: Progressive Supranuclear Palsy - Atypical Parkinsonism
Location: Boston, MA
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) - NCT00382824-35294
Conditions: Progressive Supranuclear Palsy - Atypical Parkinsonism
Location: Birmingham, AL
- Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism - NCT00745030-60611
Conditions: REM Behavior Disorder - Parkinsonism
Location: Chicago, IL
- Efficacy of Voice Treatment for Parkinson's Disease - NCT00123084-
Conditions: Parkinson's Disease - Dysphagia - Dysarthria
Location: San Antonio, TX
- Efficacy of Voice Treatment for Parkinson's Disease - NCT00123084-80204
Conditions: Parkinson's Disease - Dysphagia - Dysarthria
Location: Denver, CO
- Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects - NCT00612872-06510
Conditions: Parkinson Disease - Alzheimer Disease - Healthy Controls - Multiple Sclerosis
Location: New Haven, CT
- Evaluation of [123I]MNI-420 and Single Photon Emission Computed Tomography (SPECT) as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease (PD) and Huntington Disease (HD) - NCT00970229-06510
Conditions: Parkinson Disease - Huntington Disease
Location: New haven, CT
- Evaluation of [18F] FEPPA and Positron Emission Tomography (PET) as a Marker of Inflammation in Subjects With Neurological Conditions - NCT00970333-06510
Conditions: Alzheimer Disease - Parkinson Disease - Multiple Sclerosis
Location: New Haven, CT
- Exercise Study For People With Parkinson's Disease - NCT00387218-80227
Conditions: Parkinson's Disease
Location: Lakewood, CO
- Exercise Study For People With Parkinson's Disease - NCT00387218-80262
Conditions: Parkinson's Disease
Location: Denver, CO
- Exercise Study For People With Parkinson's Disease - NCT00387218-80303
Conditions: Parkinson's Disease
Location: Boulder, CO
- Exercise Study For People With Parkinson's Disease - NCT00387218-80933
Conditions: Parkinson's Disease
Location: Colorado Springs, CO
- Expiratory Muscle Training for Persons With Neurodegenerative Disease - NCT00856518-32608
Conditions: Parkinson's Disease - Multiple Sclerosis
Location: Gainesville, FL
- Florpiramine F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients - NCT00857532-19104
Conditions: Parkinson's Disease
Location: Philadelphia, PA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-19104
Conditions: Parkinson Disease
Location: Philadelphia, PA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-19107
Conditions: Parkinson Disease
Location: Philadelphia, PA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-23249
Conditions: Parkinson Disease
Location: Richmond, VA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-23298
Conditions: Parkinson Disease
Location: Richmond, VA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-77030A
Conditions: Parkinson Disease
Location: Houston, TX
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-77030B
Conditions: Parkinson Disease
Location: Houston, TX
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-90073
Conditions: Parkinson Disease
Location: West Los Angeles, CA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-90095
Conditions: Parkinson Disease
Location: Los Angeles, CA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-94121
Conditions: Parkinson Disease
Location: San Francisco, CA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-94143
Conditions: Parkinson Disease
Location: San Francisco, CA
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-97201
Conditions: Parkinson Disease
Location: Portland, OR
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation - NCT01022073-97239
Conditions: Parkinson Disease
Location: Portland, OR
- Healthcare Utilization and Functional Disability in Parkinson's Disease - NCT00360633-10021
Conditions: Parkinson's Disease
Location: New York, NY
- High and Low Dose Treatment of Carbidopa in Parkinson's Disease - NCT00745277-97239
Conditions: Parkinson's Disease
Location: Portland, OR
- Identification, Prevalence, and Lifespan of Rapid-Onset Dystonia-Parkinsonism - NCT00682513-27157
Conditions: Dystonia - Parkinsonism
Location: Winston-Salem, NC
- Investigation of PYM50028, an Oral Neurotrophic Factor Inducing Drug: Potential Early-stage Novel Therapy for Parkinson's Disease (PD) - NCT01060878-
Conditions: Parkinson's Disease
Location: Tbc, NY
- Levodopa-carbidopa Intestinal Gel Open-label Study in Advanced PD - NCT00335153-
Conditions: Advanced Parkinson's Disease
Location: Milwaukee, WI
- Lubiprostone as a Treatment for Constipation in Parkinson's Disease - NCT00669461-72205
Conditions: Constipation - Parkinson's Disease
Location: Little Rock, AR
- Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers - NCT00001284-20892
Conditions: Healthy - Mental Disorder - Parkinson's Disease - Schizophrenia
Location: Bethesda, MD
- Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers - NCT00004571-20892
Conditions: Bipolar Disorder - Healthy - Mood Disorder - Parkinson's Disease - Schizophrenia
Location: Bethesda, MD
- Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD) - NCT00847431-45267
Conditions: Parkinson's Disease - Depression - Anxiety
Location: Cincinnati, OH
- Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD) - NCT00847431-63110
Conditions: Parkinson's Disease - Depression - Anxiety
Location: St. Louis, MO
- Memory Disorders Registry - NCT00654563-90048
Conditions: Dementia - Alzheimer's Disease - Parkinson Disease - Huntington Disease
Location: Los Angeles, CA
- Molecular Epidemiology of Parkinson's Disease - NCT00042107-55905
Conditions: Parkinson Disease
Location: Rochester, MN
- Natural History of Levodopa-Induced Dyskinesia (LID) - NCT01003002-97239
Conditions: Parkinson's Disease
Location: Portland, OR
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-02115
Conditions: Parkinson's Disease
Location: Boston, MA
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-02215
Conditions: Parkinson's Disease
Location: Boston, MA
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-03756
Conditions: Parkinson's Disease
Location: Lebanon, NH
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-05405
Conditions: Parkinson's Disease
Location: Burlington, VT
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-06510
Conditions: Parkinson's Disease
Location: New Haven, CT
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-08901
Conditions: Parkinson's Disease
Location: New Brunswick, NJ
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-11030
Conditions: Parkinson's Disease
Location: Manhasset, NY
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-11203
Conditions: Parkinson's Disease
Location: Brooklyn, NY
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-19096
Conditions: Parkinson's Disease
Location: Wynnewood, PA
- NET-PD LS-1 Creatine in Parkinson's Disease - NCT00449865-19107A
Conditions: Parkinson's Disease
Location: Philadelphia, PA
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|